Gestational Changes in eGFR among Patients with CKD

Background: Chronic kidney disease (CKD) affects ~3% of women of childbearing age and is a risk factor for adverse pregnancy outcomes. In normal pregnancy, glomerular filtration rate (GFR) increases by 40-50%. Pregnant patients with CKD may have a blunted gestational increase in GFR. This study aimed to explore if lower baseline eGFR is associated with a lower gestational increase in eGFR among pregnant patients with CKD. Methods: This was a single-center retrospective study of pregnant women age ≥18 who received care at a multidisciplinary high-risk obstetric nephrology clinic between 2011-2023. All subjects had CKD, defined as eGFR < 60 ml/min/1.73m2 or urine protein:creatinine ratio (UPCR) >150 mg/mg prior to pregnancy, or UPCR >300 mg/mg prior to 20 weeks gestation. eGFR was calculated using the 2021 CKD-EPI Cr equation. Baseline eGFR was calculated from the last serum Cr prior to and within 2 years of pregnancy. Gestational % change in eGFR was calculated from the baseline eGFR and the peak mid-pregnancy eGFR, measured between 13-28 weeks gestation. Pearson’s correlation was used to assess the correlation between baseline eGFR and gestational change in eGFR. Results: 47 patients were included in the study. 5 (10.6%) had diabetes mellitus, and 15 (31.9%) had chronic hypertension. At the initial prenatal visit, 41 (87.2%) had proteinuria, 13 (37.1%) had eGFR 30-59, and 2 (5.7%) had eGFR 15-29. Median eGFR prior to pregnancy was 91.2 ml/min/1/73 m2 (IQR 58.8-119.0), and median peak eGFR during pregnancy was 105.2 (IQR 59.6-133.9). The median absolute change in eGFR was 11 ml/min/1.73 m2 (IQR 3.9-18.6), and median percent change was +13% (IQR +4-26.9%). There was no correlation between baseline eGFR and gestational change in eGFR (Pearson correlation coefficient -0.065, p=0.6647). 18 patients (39.1%) developed preeclampsia. Conclusion: We found no correlation between baseline eGFR and gestational change in eGFR in patients with CKD. Limitations included a small number of patients with very low eGFR. Our patients with CKD had a smaller gestational increase in GFR than has been reported in pregnant patients with normal kidney function.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2024-10-01
DOI
https://doi.org/10.1681/asn.2024nqfgr5xj
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Gestational Changes in eGFR among Patients with CKD

Anam Ali, Sharon E. Maynard, Shae Duka
Journal of the American Society of Nephrology
Pregnancy and preeclampsia studies
article

Gestational Changes in eGFR among Patients with CKD

Anam Ali, Sharon E. Maynard, Shae Duka
article en

Abstract

Background: Chronic kidney disease (CKD) affects ~3% of women of childbearing age and is a risk factor for adverse pregnancy outcomes. In normal pregnancy, glomerular filtration rate (GFR) increases by 40-50%. Pregnant patients with CKD may have a blunted gestational increase in GFR. This study aimed to explore if lower baseline eGFR is associated with a lower gestational increase in eGFR among pregnant patients with CKD. Methods: This was a single-center retrospective study of pregnant women age ≥18 who received care at a multidisciplinary high-risk obstetric nephrology clinic between 2011-2023. All subjects had CKD, defined as eGFR < 60 ml/min/1.73m2 or urine protein:creatinine ratio (UPCR) >150 mg/mg prior to pregnancy, or UPCR >300 mg/mg prior to 20 weeks gestation. eGFR was calculated using the 2021 CKD-EPI Cr equation. Baseline eGFR was calculated from the last serum Cr prior to and within 2 years of pregnancy. Gestational % change in eGFR was calculated from the baseline eGFR and the peak mid-pregnancy eGFR, measured between 13-28 weeks gestation. Pearson’s correlation was used to assess the correlation between baseline eGFR and gestational change in eGFR. Results: 47 patients were included in the study. 5 (10.6%) had diabetes mellitus, and 15 (31.9%) had chronic hypertension. At the initial prenatal visit, 41 (87.2%) had proteinuria, 13 (37.1%) had eGFR 30-59, and 2 (5.7%) had eGFR 15-29. Median eGFR prior to pregnancy was 91.2 ml/min/1/73 m2 (IQR 58.8-119.0), and median peak eGFR during pregnancy was 105.2 (IQR 59.6-133.9). The median absolute change in eGFR was 11 ml/min/1.73 m2 (IQR 3.9-18.6), and median percent change was +13% (IQR +4-26.9%). There was no correlation between baseline eGFR and gestational change in eGFR (Pearson correlation coefficient -0.065, p=0.6647). 18 patients (39.1%) developed preeclampsia. Conclusion: We found no correlation between baseline eGFR and gestational change in eGFR in patients with CKD. Limitations included a small number of patients with very low eGFR. Our patients with CKD had a smaller gestational increase in GFR than has been reported in pregnant patients with normal kidney function.

Journal of the American Society of NephrologyVol. 35(10S)
Lehigh Valley Health Network (US)
Zero hunger
Openalex Percentile: Top 70%
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.